Weight Loss & MetabolicResearch Chemical

5-Amino-1MQ

Also known as: 5-amino-1-methylquinolinium

NNMT-inhibiting compound popular in the peptide market for fat metabolism and metabolic health.

Oral

Weight Loss & Metabolic

5-Amino-1MQ

OralResearch Chemical

Technically a small molecule, not a peptide. Research use only; no human clinical validation. Not FDA-approved.

Overview

5-Amino-1MQ is a small molecule (commonly sold alongside research peptides) that inhibits the enzyme nicotinamide N-methyltransferase (NNMT). By blocking NNMT it is studied for boosting cellular NAD+ and encouraging fat cells to burn rather than store energy.

5-Amino-1MQ is technically a small molecule rather than a true peptide, but it is sold and discussed right alongside metabolic peptides, so it belongs in the conversation. It works by inhibiting an enzyme called NNMT (nicotinamide N-methyltransferase), which is overexpressed in the fat tissue of people who are overweight. When NNMT is overactive it effectively encourages fat cells to store rather than burn energy and drains cellular NAD+.

By blocking NNMT, 5-Amino-1MQ is studied for raising NAD+ and SAM levels, nudging fat cells toward burning energy, and increasing metabolic rate. In animal models, NNMT inhibition reduces diet-induced obesity and improves metabolic markers. The catch is that human clinical data is essentially absent — it is widely marketed for fat loss and NAD+ support, but that marketing currently outpaces the proof.

Mechanism of Action

Inhibits NNMT, an enzyme overexpressed in adipose tissue. NNMT inhibition raises NAD+ and SAM levels, increasing metabolic rate in fat cells and reducing fat storage in preclinical models.

Use Cases

  • Fat metabolism and body composition
  • Metabolic rate support
  • NAD+ and cellular energy

Research Summary

Animal studies show NNMT inhibition reduces diet-induced obesity and improves metabolic markers. Human data is lacking; it is widely marketed but clinically unproven.

Explain It Like I'm 5 Years Old

Inside fat cells there is a switch that decides whether to store energy or burn it. In people carrying extra weight, that switch often gets stuck on store. 5-Amino-1MQ flips the switch back toward burn, and at the same time helps top up a fuel called NAD+ that your cells use for energy. In animals it helps them stay lean — in people, it is still being figured out.

How the Gym Bros Are Using It

The oral fat-loss compound that keeps popping up in cutting stacks. Because it is a pill and targets fat metabolism plus NAD+, people run it during a deficit hoping for easier fat loss and better energy. Common marketed dosing is 50 to 150 mg a day. Reality check: it is a small molecule, not a peptide, and the human evidence is basically not there yet, so keep expectations modest and treat the hype with some skepticism.

Typical Dosing

Marketed oral protocols: 50–150 mg per day. Not a medical recommendation.

Administration

Oral

Research Chemical

Technically a small molecule, not a peptide. Research use only; no human clinical validation. Not FDA-approved.

Related Peptides

Verified Sources for 5-Amino-1MQ

Browse all →

Clinics Offering 5-Amino-1MQ Therapy